Authors
De-Han Cai, Ming-Jie He, Chuan-Hong Wang, Li-Xue Dai, Xiao-Lin Fang
Published in
Medicine. Volume 105. Issue 33. Pages e50206. Aug 14, 2026.
Abstract
This study retrospectively analyzes the clinical characteristics of talaromycosis in human immunodeficiency virus (HIV)-positive and HIV-negative hosts. Seven cases of HIV-positive hosts and 23 cases of HIV-negative hosts infected with Talaromyces marneffei were collected. Their respective clinical characteristics were compared. Patients in the HIV-negative group were more likely to have chest tightness and dyspnea, higher peripheral blood leukocyte counts, CD4+ T-lymphocyte values, CD4+ T/CD8+ T ratios, and cavities, nodules, and masses in the lungs. Patients in the HIV-positive group were more likely to have mediastinal, hilar, and distal lymph node enlargements. Patients in the HIV-negative group were more likely to have dual infections, and those in the HIV-positive group were more likely to have multiple infections. The mortality rate was higher in the HIV-negative group. Talaromycosis in HIV-negative hosts has more severe intrapulmonary lesions and a higher mortality rate and should be given more attention. Patients with talaromycosis, whether in HIV-positive or HIV-negative hosts, should be actively screened for possible coinfections.
PMID:
42601759
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0